Sort
15,273 grants matching “antimicrobial resistance”
Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens
$989,678Mark Geisberg · Silver Lake Research Corporation · R42 · FY2017 · AI
Near patient molecular diagnostics test for infections
$989,569Vincent Jen-Jr Gau · Genefluidics, Inc. · SB1 · FY2016 · AI
An Integrated Diagnostic System for Rapid Antimicrobial Susceptibility Testing
$989,486Vincent Jen-Jr Gau · Genefluidics, Inc. · R44 · FY2013 · AI
Multivalent Adjuvant Immunization to Prevent Hospital Acquired Infections
$989,399Brad J Spellberg · Exbaq Llc · R42 · FY2023 · AI
Bone targeted delivery of an antimicrobial drug for osteomyelitis therapy
$988,634Frank H. Ebetino · Biovinc, Llc · R44 · FY2022 · AI
Novel polymeric materials with improved durability in the oral environment: tailoring responses to host and bacterial enzymes with anti-proteolytic and ecology-based antimicrobial approaches.
$988,540Carmem S. Pfeifer · Oregon Health & Science University · R35 · FY2020 · DE
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform
$988,510Aaron R. Hawkins · Brigham Young University · R01 · FY2018 · AI
Clonotyping Technology for Prediction of Antibiotic Resistance
$987,986Evgeni Veniaminovic Sokurenko · Idgenomics, Inc. · R42 · FY2017 · AI
Preclinical development of Novo29, a new antibiotic
$987,424Losee Lucy Ling · Novobiotic Pharmaceuticals, Llc · R44 · FY2020 · AI
An Integrated Diagnostic System for Rapid Antimicrobial Susceptibility Testing
$987,161Vincent Jen-Jr Gau · Genefluidics, Inc. · R44 · FY2014 · AI
The role of CD40L in resistance to enteric infection
$986,966Christopher A Hunter · University Of Pennsylvania · U01 · FY2023 · AI
Therapy Against Recalcitrant C. albicans Infection
$986,559Thomas A Dahl · Arietis · R44 · FY2010 · AI
Drug Discovery from Slow Growing and Rare Microbial Species
$986,467Amy Lynn Spoering · Novobiotic Pharmaceuticals, Llc · R44 · FY2014 · AI
Diagnostic tool for assessment and tracking of microbial load in bloodstream infections
$985,142Alon Singer · Helixbind, Inc. · R44 · FY2024 · AI
An Integrated Device for Rapid Bacteremia Diagnosis from Whole Blood
$985,030Alon Singer · Helixbind, Inc. · R44 · FY2016 · AI
SBIR Phase II: Phage-amplified Identification and Antimicrobial Susceptibility Test
$984,381Christopher Cox · Cobio Diagnostics Inc. · · FY2024 · TIP
Mapping polymicrobial interactions that modulate antibiotic persistence
$984,000Wendy W.k. Mok · University Of Connecticut Sch Of Med/Dnt · DP2 · FY2024 · AI
An Integrated Device for Rapid Bacteremia Diagnosis from Whole Blood
$983,964Alon Singer · Helixbind, Inc. · R44 · FY2017 · AI
Multivalent Adjuvant Immunization to Prevent Hospital Acquired Infections
$983,543Brad J Spellberg · Exbaq Llc · R42 · FY2024 · AI
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
$983,072Christie G. Brouillette · University Of Alabama At Birmingham · U01 · FY2009 · AI
Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes
$982,704Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2023 · AI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform
$982,407Aaron R. Hawkins · Brigham Young University · R01 · FY2019 · AI
Next-generation phenotypic antimicrobial susceptibility test platform: rapid resultsand comprehensive menus
$981,971Eric Stern · Selux Diagnostics, Inc. · SB1 · FY2022 · AI
Sialic acid analogs against multidrug-resistant gonorrhea
$981,731Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI
DHODH Inhibitors: A Potential New Class of Antimicrobials for Treatment of the Drug Resistant Gram-Negative Bacillus Acinetobacter baumannii
$981,697Thomas A Russo · State University Of New York At Buffalo · R56 · FY2018 · AI